Puretech Health Plc Stock Performance
| PRTC Stock | USD 18.80 0.11 0.59% |
PureTech Health has a performance score of 5 on a scale of 0 to 100. The company holds a Beta of 0.66, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PureTech Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding PureTech Health is expected to be smaller as well. PureTech Health PLC right now holds a risk of 2.81%. Please check PureTech Health PLC expected short fall, and the relationship between the value at risk and daily balance of power , to decide if PureTech Health PLC will be following its historical price patterns.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in PureTech Health PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, PureTech Health may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
| Begin Period Cash Flow | 191.1 M | |
| Total Cashflows From Investing Activities | 240.9 M |
PureTech Health Relative Risk vs. Return Landscape
If you would invest 1,724 in PureTech Health PLC on November 6, 2025 and sell it today you would earn a total of 156.00 from holding PureTech Health PLC or generate 9.05% return on investment over 90 days. PureTech Health PLC is currently generating 0.1806% in daily expected returns and assumes 2.806% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than PureTech, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PureTech Health Target Price Odds to finish over Current Price
The tendency of PureTech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 18.80 | 90 days | 18.80 | about 6.37 |
Based on a normal probability distribution, the odds of PureTech Health to move above the current price in 90 days from now is about 6.37 (This PureTech Health PLC probability density function shows the probability of PureTech Stock to fall within a particular range of prices over 90 days) .
PureTech Health Price Density |
| Price |
Predictive Modules for PureTech Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PureTech Health PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PureTech Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PureTech Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. PureTech Health is not an exception. The market had few large corrections towards the PureTech Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PureTech Health PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PureTech Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | 0.66 | |
σ | Overall volatility | 1.01 | |
Ir | Information ratio | 0.04 |
PureTech Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PureTech Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PureTech Health PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PureTech Health PLC currently holds about 368.03 M in cash with (134.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. |
PureTech Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PureTech Stock often depends not only on the future outlook of the current and potential PureTech Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PureTech Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27 M | |
| Cash And Short Term Investments | 367.3 M |
PureTech Health Fundamentals Growth
PureTech Stock prices reflect investors' perceptions of the future prospects and financial health of PureTech Health, and PureTech Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PureTech Stock performance.
| Return On Equity | 0.0944 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | 7.93 % | ||||
| Operating Margin | (25.90) % | ||||
| Current Valuation | 140.37 M | ||||
| Shares Outstanding | 24.17 M | ||||
| Price To Book | 1.23 X | ||||
| Price To Sales | 70.68 X | ||||
| Revenue | 4.83 M | ||||
| EBITDA | 37.38 M | ||||
| Cash And Equivalents | 368.03 M | ||||
| Cash Per Share | 12.84 X | ||||
| Total Debt | 22.36 M | ||||
| Debt To Equity | 0.08 % | ||||
| Book Value Per Share | 1.56 X | ||||
| Cash Flow From Operations | (134.37 M) | ||||
| Earnings Per Share | 1.70 X | ||||
| Total Asset | 602.63 M | ||||
| Retained Earnings | 32.49 M | ||||
About PureTech Health Performance
By analyzing PureTech Health's fundamental ratios, stakeholders can gain valuable insights into PureTech Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PureTech Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PureTech Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PureTech Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.Things to note about PureTech Health PLC performance evaluation
Checking the ongoing alerts about PureTech Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PureTech Health PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PureTech Health PLC currently holds about 368.03 M in cash with (134.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. |
- Analyzing PureTech Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PureTech Health's stock is overvalued or undervalued compared to its peers.
- Examining PureTech Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PureTech Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PureTech Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PureTech Health's stock. These opinions can provide insight into PureTech Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PureTech Stock analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |